CNTA vs CUBE · $6.15B cap vs P/E 25, rev $1.07B
Centessa Pharmaceuticals PLC ADR (CNTA) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CNTA currently screens at market cap $6.15B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CNTA and CUBE stock pages for the full models.
Not investment advice.